Intraoperative Neuromonitoring (IONM) Market: Growth & Revenue Opportunities by Top Key Players Accurate Monitoring, LLC., Computational Diagnostics, Inc., Intranerve, LLC., Inomed Medizintechnik GmbH, Medtronic Plc, Moberg Research, Inc. (DAYONE MEDICAL,

U.S. intraoperative neuromonitoring (IONM) market is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6%.

The key players profiled in this report include
• Accurate Monitoring LLC.
• Computational Diagnostics Inc.
• Intranerve LLC.
• Inomed Medizintechnik GmbH
• Medtronic Plc
• Moberg Research
• Inc. (Dayone Medical LLC.)
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Nuvasive Inc.
• Specialtycare.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/5034?utm_source=sy_Openpr

The IONM system segment accounted for nearly half of the total market in 2015. These systems help to identify neural structures during a surgery. This helps the surgeons to prevent any damage to the nervous system, which may be caused during the surgery and also reduce post-operative complications. The U.S. IONM market is driven by rise in number of surgeries, increase in geriatric population, growth in prevalence of chronic disorders, and surge in adoption of IONM during complex surgeries.

Based on source type, the U.S. IONM market is bifurcated as outsourced monitoring and insourced monitoring. The outsourced monitoring segment is expected to grow at the highest CAGR, owing to its benefits over insourced monitoring. At present, hospitals generally do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set, and they cannot offer the training standardization to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ambulatory surgical centers (ASCs).

Based on product & service, the U.S. IONM market is categorized as system, accessory, and service. The system segment dominates the U.S. IONM market, owing to its critical role in every IONM procedure. On the other side, the service segment is expected to exhibit the fastest market growth during the forecast period, owing to increase in demand for IONM service providers. Based on modality, the U.S. IONM market is segmented into somatosensory evoked potential (SSEP), motor evoked potential (MEP), electromyography (EMG), electroencephalography (EEG), visual evoked potential (VEP), and brainstem auditory evoked potential (BAEP). The EMG segment was the major revenue contributor in 2015 and is estimated to remain dominant during the forecast period, owing to its applicability in complex surgery. However, the BAEP segment is expected to show the fastest market growth during the forecast period, owing to technological advancements and rise in adoption of BAEPs.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/5034?utm_source=sy_Openpr


Based on application, the U.S. IONM market is categorized into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and other surgeries. The spinal surgery segment was the highest revenue contributor to the U.S. IONM market in 2015, owing to increase in number of spinal surgeries in the U.S and recommended use of IONM during spinal surgery. However, the orthopedic surgery segment is projected to exhibit the fastest market growth during the forecast period, owing to increase in adoption of IONM during orthopedic surgery.

Based on end user, the U.S. IONM market is classified into hospital and ambulatory surgical center (ASC). The hospital segment was the major revenue contributor in 2015, owing to increase in number of hospitals, growth in number of surgeries, and rise in outsourced monitoring within hospitals. However, the ambulatory surgery center segment is expected to exhibit rapid growth during the forecast period, owing to rise in number of surgeries within ambulatory surgery centers.

State-wise, the market is studied across all the states in U.S., California was the major revenue generating state in 2015, owing to increased usage of IONM procedures, surge in number of neurosurgery & orthopedic surgeries, easy availability of trained medical professionals, presence of developed healthcare infrastructure with higher healthcare spending. However, Washington will witness the fastest market growth over the forecast period, owing to the growing adoption of IONM in various surgical procedures, increasing incidence of chronic diseases, and rising healthcare spending among the population.

Buy Report From @ https://www.alliedmarketresearch.com/checkout/972325?utm_source=sy_Openpr

Key Finding of the Intraoperative Neuromonitoring Market:
• Based on application, the spinal surgery segment accounted for more than one-fourth of the total market in 2015.
• As per modality, the electromyography (EMG) segment accounted for more than one-fourth of the U.S. market in 2015.
• According to product & service, the IONM service segment is expected to grow at a high CAGR of 9.4% during the forecast period, owing to an increase in the demand for IONM service providers.
• On the basis of end user, the hospital segment accounted for nearly half of the total market share in 2015.
• State-wise, Washington is expected to grow at a CAGR of 10.1% during the forecast period 2016 to 2022.

Access Full Summery @ https://www.alliedmarketresearch.com/us-intraoperative-neuromonitoring-market?utm_source=sy_Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.